Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Predicting COVID-19 transmission dynamics in the USA

Predicting COVID-19 transmission dynamics in the USA

3 Dec 2021
Subcutaneously administered monoclonal antibodies associated with reduced hospitalization and death amongst COVID 19 outpatients

Subcutaneously administered monoclonal antibodies associated with reduced hospitalization and death amongst COVID 19 outpatients

3 Dec 2021
Characterization of two novel SARS-CoV-2 delta variant sublineages

Characterization of two novel SARS-CoV-2 delta variant sublineages

3 Dec 2021
CRISPR-based DETECTR® assay for faster SARS-CoV-2 surveillance

CRISPR-based DETECTR® assay for faster SARS-CoV-2 surveillance

3 Dec 2021
Risk of COVID-19 hospitalization among children with markers of uncontrolled asthma

Risk of COVID-19 hospitalization among children with markers of uncontrolled asthma

3 Dec 2021
Novel peptide-antibody fusion molecule enhances SARS-CoV-2 variant neutralization

Novel peptide-antibody fusion molecule enhances SARS-CoV-2 variant neutralization

3 Dec 2021
Study finds third dose of BNT162b2 or mRNA-1273 is moderately effective against post-vaccination COVID-19 infection

Study finds third dose of BNT162b2 or mRNA-1273 is moderately effective against post-vaccination COVID-19 infection

3 Dec 2021
Pediatric COVID-19 and PIMS-TS: hospitalization, severe disease and mortality risk

Pediatric COVID-19 and PIMS-TS: hospitalization, severe disease and mortality risk

3 Dec 2021
Modeling emergence and dynamics of new COVID-19 variants in the UK

Modeling emergence and dynamics of new COVID-19 variants in the UK

3 Dec 2021
Hybrid immunity provides the highest and most durable immunity against SARS-CoV-2 infection

Hybrid immunity provides the highest and most durable immunity against SARS-CoV-2 infection

2 Dec 2021
Green seaweed extract exhibits anti-SARS-CoV-2 activity in vitro

Green seaweed extract exhibits anti-SARS-CoV-2 activity in vitro

2 Dec 2021
Investigating the zoonotic adaptation and anthropozoonotic transmission of SARS-CoV-2

Investigating the zoonotic adaptation and anthropozoonotic transmission of SARS-CoV-2

2 Dec 2021
New bioinformatics method for viral sgRNA analysis

New bioinformatics method for viral sgRNA analysis

2 Dec 2021
Study explores the emergence and spread of SARS-CoV-2 Delta variant across Brazil

Study explores the emergence and spread of SARS-CoV-2 Delta variant across Brazil

2 Dec 2021
Impact of SARS-CoV-2 infection on testis function

Impact of SARS-CoV-2 infection on testis function

2 Dec 2021
New insights offered into cell-to-cell propagation of SARS-CoV-2

New insights offered into cell-to-cell propagation of SARS-CoV-2

2 Dec 2021
Systematic survey of human SARS-CoV-2 monoclonal antibodies

Systematic survey of human SARS-CoV-2 monoclonal antibodies

2 Dec 2021
Study suggests efficacy of SARS-CoV-2 main protease inhibitors is not compromised in current COVID-19 variants

Study suggests efficacy of SARS-CoV-2 main protease inhibitors is not compromised in current COVID-19 variants

2 Dec 2021
Preventing SARS-CoV-2 transmission at large indoor events

Preventing SARS-CoV-2 transmission at large indoor events

2 Dec 2021
Researchers report antibody cocktails are promising candidate tools for controlling new SARS-CoV-2 variants

Researchers report antibody cocktails are promising candidate tools for controlling new SARS-CoV-2 variants

2 Dec 2021

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback